Administration, Inhalation
"Administration, Inhalation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.
| Descriptor ID |
D000280
|
| MeSH Number(s) |
E02.319.267.050
|
| Concept/Terms |
Administration, Inhalation- Administration, Inhalation
- Drug Administration, Respiratory
- Administration, Respiratory Drug
- Respiratory Drug Administration
- Inhalation Drug Administration
- Drug Administration, Inhalation
- Administration, Inhalation Drug
- Inhalation Administration
Drug Aerosol Therapy- Drug Aerosol Therapy
- Aerosol Therapy, Drug
- Therapy, Drug Aerosol
- Drug Therapy, Aerosol
- Aerosol Drug Therapy
- Therapy, Aerosol Drug
|
Below are MeSH descriptors whose meaning is more general than "Administration, Inhalation".
Below are MeSH descriptors whose meaning is more specific than "Administration, Inhalation".
This graph shows the total number of publications written about "Administration, Inhalation" by people in this website by year, and whether "Administration, Inhalation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 3 | 3 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 3 | 3 |
| 2017 | 5 | 109 | 114 |
| 2018 | 4 | 98 | 102 |
| 2019 | 0 | 40 | 40 |
| 2020 | 1 | 30 | 31 |
| 2021 | 0 | 33 | 33 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Inhalation" by people in Profiles.
-
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19. Eur Respir J. 2021 10; 58(4).
-
Nanoparticle-mediated surfactant therapy in patients with severe COVID-19: a perspective. J Mater Chem B. 2021 09 15; 9(35):6988-6993.
-
Delayed positive COVID19 nasopharyngeal test, a case study with clinical and pathological correlation. BMC Pulm Med. 2021 Aug 31; 21(1):278.
-
Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19. Clin Transl Sci. 2021 11; 14(6):2556-2565.
-
Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery. J Drug Target. 2022 03; 30(3):233-243.
-
Inhaled corticosteroids in early COVID-19-A tale of many facets. Allergy. 2021 11; 76(11):3540-3542.
-
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis. Crit Care. 2021 08 19; 25(1):298.
-
High-Dose Nitric Oxide From Pressurized Cylinders and Nitric Oxide Produced by an Electric Generator From Air. Respir Care. 2022 02; 67(2):201-208.
-
Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia. Nitric Oxide. 2021 11 01; 116:7-13.
-
Effects of inhaled nitric oxide in COVID-19-induced ARDS-Is it worthwhile? Acta Anaesthesiol Scand. 2021 11; 65(10):1522-1523.